期刊文献+

脑组织特异表达S100B转基因小鼠的建立 被引量:3

Establishment of Brain-Specific S100B Transgenic Mice
下载PDF
导出
摘要 目的S100B在多种神经损伤性疾病中高表达,高浓度的S100B蛋白对中枢神经系统具有毒性作用。建立脑组织特异表达S100B转基因小鼠,用于研究该基因在帕金森病(Parkinson's disease,PD)发病中的作用。方法ELISA法检测S100B蛋白在α-synuclein A53T转基因小鼠脑组织中的表达情况。构建PDGF-hS100B表达载体,显微注射法建立S100B转基因小鼠。PCR鉴定转基因鼠的基因型,Western blot检测基因表达水平。Rota-rod实验检测S100B转基因鼠的运动协调能力。结果S100B在9月龄和12月龄α-synucleinA53T转基因小鼠脑组织中的表达高于野生型小鼠。建立了2个品系的脑组织特异表达S100B转基因小鼠。与野生型小鼠相比S100B转基因小鼠表现出明显的进行性运动协调能力障碍。结论S100B转基因小鼠的建立为研究该基因在PD中的作用提供了工具。 Objective To establish a brain specific S100B gene transgenic mice and investigate its effect on the development of Parkinson's disease(PD).Methods The expression of S100B protein in the brain of α-synuclein A53T transgenic mice was detected by ELISA.The expression vector of PDGF-hS100B was constructed.The transgenic mice were produced by microinjection and the genotyping was detected by PCR.The expression levels of the transgenic gene were detected by Western blot.Motor coordination of the S100B transgenic and control mice was detected by Rota-rod test.Results The expression of S100B protein in the brain of 9-and 12-month old α-synuclein A53T transgenic mice was higher than that of the wild type mice.Five founders of brain specific PDGF-hS100B transgenic mice were established and two high-level expression lines were identified.Compared with the wild type mice,S100B transgenic mice showed apparently progressive decline in motor coordination assessed by Rota-rod test.Conclusion The transgenic mice with brain specific expression of human S100B gene have been established and it can be used to investigate the function of S100B gene on the development of Parkinson's disease.
出处 《中国比较医学杂志》 CAS 2010年第4期24-27,共4页 Chinese Journal of Comparative Medicine
基金 卫生部项目:实验动物和人类疾病动物模型资源扩展(200802036) 十一五新药专项支持(2009ZX09501-026) 中央级公益性科研院所基本科研业务费专项基金(DWS200808)
关键词 Α-SYNUCLEIN A53T S100B 小鼠 转基因 α-synuclein A53T S100B Mice Transgenic Brain Parkinson's disease
  • 相关文献

参考文献3

二级参考文献21

  • 1萨姆布鲁克J 拉塞尔DW 黄培堂译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.. 被引量:75
  • 2Kruger R,Kulm W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinsen' s disease [ J ]. Nat Genet, 1998,18:106- 108. 被引量:1
  • 3Ulmer T S, Bax A. Comparison of structureand dynamics ofmiceilebound human alpha-synuclein and Parkinson disease variants [J]. J Biol Chem,2005,280(52) :43179 - 43187. 被引量:1
  • 4Lee JM, Yah P,Michael KL, et al. Parkinson's disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death[ J ]. J Neurosci ,2006,26( 1 ) :41 - 50. 被引量:1
  • 5Van der Putten H, Wiederhold KH, Probst A, et al. Neuropathology in mice expressing human alpha-synuclein [ J ]. J Neurosci, 2000,20 (16) :6021 - 6029. 被引量:1
  • 6Gispert S,Del Turco D,Garrett L,et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation[ J ]. Mol Cell Neurosci, 2003,24 (2) : 419 - 429. 被引量:1
  • 7Poon HF, Frasier M, Shreve N, et al. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenlc mice-a model of familial Parkinson' s disease [J]. Neurobiol Dis,2005,18(3) :492 - 498. 被引量:1
  • 8Schober A. Classic toxin-induced animal models of Parkinson' s disease:6-OHDA and MPTP[J]. Cell Tissue Res,2004,318( 1 ) :215 - 224. 被引量:1
  • 9Shirakashi Y, Kawamoto Y, Tomimoto H, et al. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice[J]. Acta Neuropathol (Berl) ,2006,112(6) :681 - 689. 被引量:1
  • 10Polymempoulos MH, Lavedan C, Lemy E, et al. Mutation in the alpha-synuclein gene identied in families with Parkinsen' s disease [J]. Science, 1997,276:2045 - 2047. 被引量:1

共引文献42

同被引文献13

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部